AbZ-Pharma GmbH
AbZ-Pharma GmbH, a prominent player in the pharmaceutical industry, is headquartered in Germany and operates extensively across Europe. Founded in 2005, the company has established itself as a leader in the development and manufacturing of high-quality generic pharmaceuticals and innovative healthcare solutions. With a focus on therapeutic areas such as oncology, cardiology, and infectious diseases, AbZ-Pharma is dedicated to enhancing patient outcomes through its unique product offerings. The company prides itself on its rigorous quality standards and commitment to research and development, which have led to several key milestones in its growth trajectory. Recognised for its market position, AbZ-Pharma GmbH continues to expand its portfolio, ensuring access to affordable medications while maintaining excellence in service delivery.
DitchCarbon Score
How does AbZ-Pharma GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AbZ-Pharma GmbH's score of 79 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
AbZ-Pharma GmbH, headquartered in Germany, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Teva Pharmaceutical Industries Limited, which influences its climate commitments and emissions reporting. As part of its corporate family relationship, AbZ-Pharma GmbH inherits climate initiatives and targets from Teva Pharmaceutical Industries Limited. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are aimed at reducing greenhouse gas emissions across their operations. While specific reduction targets for AbZ-Pharma GmbH are not detailed, the overarching goals set by Teva Pharmaceutical Industries Limited guide their climate strategy. These initiatives reflect a commitment to sustainability and reducing environmental impact, aligning with industry standards for climate action. In summary, while AbZ-Pharma GmbH does not report its own emissions data, it is actively engaged in climate commitments through its parent company, Teva Pharmaceutical Industries Limited, which sets the framework for its environmental initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 438,420,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 613,541,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
AbZ-Pharma GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
